Rivastigmine Transdermal System Patch, Extended Release
Product Images NDC 72162-1608

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Rivastigmine Transdermal System (NDC 72162-1608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Lbl721621608)

Label (Lbl721621608)
This text appears to be a description of a medication called Rivastigmine Transdermal System. The system consists of patches containing 4.6 mg of Rivastigmine, which are to be applied to intact skin every 24 hours. Each patch should be worn for 24 hours and not cut. The system comes in a package of 30 patches. The recommended storage temperature is between 15°C and 30°C (59°F to 86°F). The manufacturer of the system is Bryant Ranch Prepack, Inc AdhexPharma, located in Burbank, CA. The text also includes safety instructions to keep the system out of reach of children and to only use it for transdermal use.*
FDA Label Image

Chemical Structure (Rivastigmine 01)

Chemical Structure (Rivastigmine 01)
FDA Label Image

Figure 1 (Rivastigmine 02)

Figure 1 (Rivastigmine 02)
FDA Label Image

Figure 2 (Rivastigmine 03)

Figure 2 (Rivastigmine 03)
FDA Label Image

Figure 3 (Rivastigmine 04)

Figure 3 (Rivastigmine 04)
FDA Label Image

Figure 4 (Rivastigmine 05)

Figure 4 (Rivastigmine 05)
FDA Label Image

Figure 5 (Rivastigmine 06)

Figure 5 (Rivastigmine 06)
FDA Label Image

Figure 6 (Rivastigmine 07)

Figure 6 (Rivastigmine 07)
FDA Label Image

Figure 7 (Rivastigmine 08)

Figure 7 (Rivastigmine 08)
Not available.*
FDA Label Image

Figure 8 (Rivastigmine 09)

Figure 8 (Rivastigmine 09)
FDA Label Image

Figure A (Rivastigmine 10)

Figure A (Rivastigmine 10)
FDA Label Image

Figure B (Rivastigmine 11)

Figure B (Rivastigmine 11)
This text is a description of different body locations where an evaluation or examination can be performed. The mentioned locations include the upper arm, side of the chest, upper back, and lower back. It is unclear what "LENGE," "Z," and "Lk" signify in this context.*
FDA Label Image

Figure C (Rivastigmine 12)

Figure C (Rivastigmine 12)
FDA Label Image

Figure D (Rivastigmine 13)

Figure D (Rivastigmine 13)
FDA Label Image

Figure E (Rivastigmine 14)

Figure E (Rivastigmine 14)
FDA Label Image

Figure F (Rivastigmine 15)

Figure F (Rivastigmine 15)
FDA Label Image

Figure G (Rivastigmine 16)

Figure G (Rivastigmine 16)
FDA Label Image

Figure H (Rivastigmine 17)

Figure H (Rivastigmine 17)
This text appears to be instructions for disposing of a slide folded patch. It advises placing the patch in the trash and folding the sticky sides together into an empty pouch that should be saved. It further emphasizes the importance of keeping the pouch away from children and pets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.